LTR Pharma (ASX:LTP) Days Sales Outstanding : 0.00 (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Days Sales Outstanding?

LTR Pharma's average Accounts Receivable for the six months ended in Jun. 2023 was A$0.00 Mil. LTR Pharma's Revenue for the six months ended in Jun. 2023 was A$0.00 Mil.

The historical rank and industry rank for LTR Pharma's Days Sales Outstanding or its related term are showing as below:

ASX:LTP's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.545
* Ranked among companies with meaningful Days Sales Outstanding only.

LTR Pharma's Days Sales Outstanding stayed the same from Jun. 2021 (0.00) to Jun. 2023 (0.00).

LTR Pharma Days Sales Outstanding Historical Data

The historical data trend for LTR Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Days Sales Outstanding Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Days Sales Outstanding

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Days Sales Outstanding	-	-	-

Competitive Comparison of LTR Pharma's Days Sales Outstanding

For the Biotechnology subindustry, LTR Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Days Sales Outstanding falls into.

LTR Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

LTR Pharma's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

LTR Pharma's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 2
=	0					/	0	*	365 / 2
=	N/A

LTR Pharma (ASX:LTP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

LTR Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines